Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Immunology · Common Variable Immunodeficiency

When the Immune System is Both Weak and Overactive: CVID and Alopecia Areata

At a Glance

CVID can cause frequent infections but may also be linked to autoimmune problems such as alopecia areata. Diagnosis requires persistent low antibody levels, impaired vaccine responses, and exclusion of other causes; some hair-loss medicines that suppress immunity need careful infection monitoring.

When a person has both Alopecia Areata (an autoimmune condition that causes hair to fall out in patches) and Common Variable Immunodeficiency (CVID), it creates a medical paradox. Your immune system is doing two opposite things at once: it is too “weak” to protect you from germs, yet “hyperactive” enough to attack your own hair follicles [1].

This combination is often referred to as “Path 1”—a scenario where two conditions occur together because of a general breakdown in how your body regulates its defenses.

What is CVID?

Common Variable Immunodeficiency (CVID) is one of the most common primary immunodeficiencies. Diagnosis generally requires a persistent, age-appropriate reduction in IgG, usually with low IgA and/or IgM, impaired specific antibody responses (such as to vaccines), and exclusion of secondary causes [2]. One low result or a single autoimmune finding does not establish CVID. While the name suggests the immune system is simply “missing” something, it is actually more complex. In CVID, the immune system often loses its ability to distinguish between “friend” and “foe” [3].

The Paradox: Weak but Overactive

It may seem strange that a body that can’t fight off a simple sinus infection would have the energy to attack its own hair. However, autoimmunity is a common complication of CVID, affecting a substantial portion of patients (around 30%, depending on the cohort studied) [4].

The most frequent autoimmune complications in CVID are:

  • Autoimmune Cytopenias: When the body attacks its own blood cells, such as platelets (ITP) or red blood cells (AIHA) [5].
  • Gastrointestinal Issues: Inflammatory bowel-like conditions or chronic diarrhea [6].
  • Endocrine Problems: Such as autoimmune thyroid disease [7].

Alopecia Areata is considered a less common autoimmune manifestation of CVID [8]. While it occurs, it is seen much less frequently than the blood or digestive issues mentioned above.

Why Does This Happen?

Scientists believe the link between CVID and alopecia lies in a failure of “immune checkpoints.” In a healthy body, Regulatory T-cells act like the “brakes” of the immune system, stopping it from attacking your own tissues. In many CVID patients, problems with these “brakes” are reported [9].

Additionally, CVID patients often have a shortage of switched-memory B-cells. These are specialized cells that have “learned” how to produce specific, effective antibodies. While not standalone diagnostic tests, these phenotypic findings suggest the immune system is disorganized, leading to both frequent infections and accidental attacks on the hair follicles [10][3].

How This Differs from Genetic Syndromes

It is important to distinguish this “Path 1” (CVID + Alopecia) from the rarer genetic syndromes (Path 2) like NFKB2 deficiency or APECED.

  • Timing: CVID-related alopecia often presents later in life (adulthood or late childhood), whereas genetic syndromes often appear in very early childhood [11]. (However, onset alone cannot rule conditions in or out).
  • Organs Affected: Genetic syndromes often involve specific “failures” of the hormone-producing glands (like the adrenal or parathyroid glands). In ordinary CVID, the autoimmune issues are more likely to target the blood, skin, or gut [12][13].
  • Genetic Cause: CVID is genetically heterogeneous. Some cases are “polygenic” (meaning it results from a complex mix of many genes), but monogenic CVID-like inborn errors (like NFKB2) are also well recognized [14].

Treatment Considerations

Managing these two conditions requires a careful balance.

  • Treating the Deficiency: The standard treatment for CVID is Immunoglobulin Replacement Therapy (IVIG or SCIG), which provides the antibodies your body is missing. This is indicated according to the confirmed defect and infection burden, not automatically for any low level. While this helps prevent lung and sinus infections, it generally does not fix the autoimmune hair loss [2][15].
  • Treating the Alopecia: Standard treatments for hair loss, such as corticosteroids or newer JAK inhibitors, work by suppressing the immune system. Because your immune system is already compromised, your doctor must use these carefully to avoid increasing your risk of serious infections [16][17].

If you have this combination, your care will ideally involve a “multidisciplinary team”—a dermatologist and an immunologist working together to ensure that treating your hair doesn’t compromise your safety [18].

Common questions in this guide

How can CVID and alopecia areata occur at the same time?
CVID can weaken the body's antibody protection against infections while also disrupting the controls that keep the immune system from attacking its own tissues. In alopecia areata, that misdirected immune activity targets hair follicles; having both conditions does not mean every case has the same underlying cause.
What findings are needed to diagnose CVID if I have hair loss?
Hair loss alone does not diagnose CVID. Doctors generally look for a persistent, age-appropriate low IgG level, often low IgA or IgM, reduced antibody responses to vaccines, and evidence that another condition is not causing the low levels.
Can IVIG or SCIG make alopecia areata grow back?
IVIG and SCIG replace antibodies and help reduce the risk of sinus and lung infections in people who need them. They generally do not correct the autoimmune attack that causes alopecia areata, so hair loss may require separate dermatology treatment.
Are steroids or JAK inhibitors safe for alopecia areata with CVID?
Corticosteroids and JAK inhibitors may be considered, but they can further suppress immune defenses and raise the risk of serious infections. A dermatologist and immunologist should decide whether the benefits outweigh the risks and should plan infection monitoring.
When should someone with CVID and alopecia ask about genetic testing?
Genetic testing may be useful when symptoms begin very early, involve several organs, or suggest a defined syndrome such as NFKB2 deficiency or APECED. Adult or late-childhood onset may fit ordinary CVID more often, but age at onset alone cannot confirm or exclude a genetic syndrome.
What does a switched-memory B-cell result tell me?
Switched-memory B cells are immune cells that have learned to help make more specific antibodies. A low count can help doctors understand the pattern of CVID and associated autoimmunity, but it is not a stand-alone test that proves or rules out CVID.

Get notified when new evidence is published on Alopecia antibody deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (18)
  1. 1

    Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2.

    Klemann C, Camacho-Ordonez N, Yang L, et al.

    Frontiers in immunology 2019; (10()):297 doi:10.3389/fimmu.2019.00297.

    PMID: 30941118
  2. 2

    An Expert Opinion/Approach: Clinical Presentations, Diagnostic Considerations, and Therapeutic Options for Gastrointestinal Manifestations of Common Variable Immune Deficiency.

    Hashash JG, Squire J, Francis FF, et al.

    The American journal of gastroenterology 2022; (117(11)):1743-1752 doi:10.14309/ajg.0000000000002027.

    PMID: 36148549
  3. 3

    Defective peripheral B cell selection in common variable immune deficiency patients with autoimmune manifestations.

    Friman V, Quinti I, Davydov AN, et al.

    Cell reports 2023; (42(5)):112446 doi:10.1016/j.celrep.2023.112446.

    PMID: 37119135
  4. 4

    Autoimmunity in common variable immunodeficiency: a systematic review and meta-analysis.

    Rizvi FS, Zainaldain H, Rafiemanesh H, et al.

    Expert review of clinical immunology 2020; (16(12)):1227-1235 doi:10.1080/1744666X.2021.1850272.

    PMID: 33203275
  5. 5

    Autoimmune Cytopenias and Associated Conditions in CVID: a Report From the USIDNET Registry.

    Feuille EJ, Anooshiravani N, Sullivan KE, et al.

    Journal of clinical immunology 2018; (38(1)):28-34 doi:10.1007/s10875-017-0456-9.

    PMID: 29080979
  6. 6

    Lessons Learned From the Clinical Presentation of Common Variable Immunodeficiency Disorders: A Systematic Review and Meta-Analysis.

    Janssen LMA, van der Flier M, de Vries E

    Frontiers in immunology 2021; (12()):620709 doi:10.3389/fimmu.2021.620709.

    PMID: 33833753
  7. 7

    Immune Dysregulation in Pediatric Common Variable Immunodeficiency: Implications for the Diagnostic Approach.

    Szczawińska-Popłonyk A, Ta Polska-Jóźwiak K, Schwartzmann E, Popłonyk N

    Frontiers in pediatrics 2022; (10()):855200 doi:10.3389/fped.2022.855200.

    PMID: 35402361
  8. 8

    Common Variable Immunodeficiency and Autoimmune Diseases: A Retrospective Study of 95 Adult Patients in a Single Tertiary Care Center.

    Mormile I, Punziano A, Riolo CA, et al.

    Frontiers in immunology 2021; (12()):652487 doi:10.3389/fimmu.2021.652487.

    PMID: 34290696
  9. 9

    Follicular T Cells from smB- Common Variable Immunodeficiency Patients Are Skewed Toward a Th1 Phenotype.

    Cunill V, Clemente A, Lanio N, et al.

    Frontiers in immunology 2017; (8()):174 doi:10.3389/fimmu.2017.00174.

    PMID: 28289412
  10. 10

    Common variable immunodeficiency-associated endotoxemia promotes early commitment to the T follicular lineage.

    Le Coz C, Bengsch B, Khanna C, et al.

    The Journal of allergy and clinical immunology 2019; (144(6)):1660-1673 doi:10.1016/j.jaci.2019.08.007.

    PMID: 31445098
  11. 11

    Clinical and Phenotypic Characterization of Common Variable Immunodeficiency Diagnosed in Younger and Older Adults.

    Fortier JC, Haltigan E, Cavero-Chavez V, et al.

    Journal of clinical immunology 2022; (42(6)):1270-1279 doi:10.1007/s10875-022-01290-w.

    PMID: 35588029
  12. 12

    Alopecia areata and occurrence of vitiligo and hypothyroidism in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients.

    Englander H, Ferré EMN, Schmitt MM, et al.

    Pediatric dermatology 2023; (40(5)):857-859 doi:10.1111/pde.15380.

    PMID: 37495514
  13. 13

    Cutaneous Manifestations in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED): A Comprehensive Review.

    Sandru F, Petca RC, Dumitrascu MC, et al.

    Biomedicines 2024; (12(1)) doi:10.3390/biomedicines12010132.

    PMID: 38255237
  14. 14

    Common Variable Immunodeficiency Disorders: A perspective from New Zealand.

    Ameratunga R, J Longhurst H, Lehnert K, et al.

    Clinical reviews in allergy & immunology 2025; (68(1)):105 doi:10.1007/s12016-025-09099-2.

    PMID: 41324804
  15. 15

    Autoimmunity in common variable immunodeficiency.

    Agarwal S, Cunningham-Rundles C

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2019; (123(5)):454-460 doi:10.1016/j.anai.2019.07.014.

    PMID: 31349011
  16. 16

    Treatment of inflammatory complications in common variable immunodeficiency (CVID): current concepts and future perspectives.

    Fevang B

    Expert review of clinical immunology 2023; (19(6)):627-638 doi:10.1080/1744666X.2023.2198208.

    PMID: 36996348
  17. 17

    Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management.

    Azizi G, Abolhassani H, Asgardoon MH, et al.

    Expert review of clinical immunology 2017; (13(2)):101-115 doi:10.1080/1744666X.2016.1224664.

    PMID: 27636680
  18. 18

    The Immune Dysregulation of Common Variable Immunodeficiency Disorders.

    Fernando SL, Jang HS, Li J

    Immunology letters 2021; (230()):21-26 doi:10.1016/j.imlet.2020.12.002.

    PMID: 33333111

This page is for informational purposes only and does not constitute medical advice or diagnose CVID or alopecia areata. Discuss your test results and treatment choices with your immunologist and dermatologist.